Implanted Stent Market Size and Forecast

The global Implanted Stent Market size was valued at USD 10.25 Billion in 2022 and is projected to reach USD 19.60 Billion by 2030, growing at a CAGR of 8.5% from 2024 to 2030. The rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and advancements in stent technology are significant factors driving the growth of the market. As healthcare infrastructure continues to improve, particularly in emerging economies, the demand for implantable stents is expected to rise steadily, contributing to overall market expansion.

Additionally, the market is benefiting from innovations in drug-eluting stents, biodegradable stents, and other advanced stent technologies that improve patient outcomes and reduce complications. The growing geriatric population, increasing awareness of heart health, and improved healthcare access in developing regions are expected to support market growth throughout the forecast period. The continuous evolution of stent designs and materials, along with favorable regulatory policies in key regions, will further enhance the market's prospects.

Download Full PDF Sample Copy of Market Report @

Implanted Stent Market Research Sample Report

Implanted Stent Market by Application

The implanted stent market, which focuses on the use of stents in medical procedures, has seen substantial growth in recent years. Stents are small mesh-like tubes inserted into narrow or blocked arteries to maintain blood flow and prevent vessel collapse. The market is categorized by application, with three main segments: coronary stents, renal stents, and carotid stents. Each of these submarkets has distinct characteristics, driven by specific health conditions and technological advancements. The demand for these stents is influenced by factors such as the prevalence of cardiovascular diseases, advancements in stent technology, and an increasing aging population. As medical innovations continue, the growth in these subsegments is expected to rise, offering improved outcomes for patients worldwide.

Coronary Stents

Coronary stents are widely used in the treatment of coronary artery disease (CAD), which is one of the leading causes of heart attacks. These stents are inserted into coronary arteries to prevent them from becoming narrowed or blocked due to the buildup of plaque. Coronary stents are primarily used in percutaneous coronary intervention (PCI) procedures, also known as angioplasty, which involves inserting the stent through a catheter to keep the artery open. The increasing prevalence of CAD, combined with the rising demand for minimally invasive procedures, has made coronary stents a cornerstone in the medical field. Additionally, advancements such as drug-eluting stents (DES), which release medication to prevent artery re-narrowing, have significantly improved patient outcomes, driving further market growth in this subsegment.

As the global population ages and lifestyle diseases such as hypertension, diabetes, and high cholesterol become more common, the demand for coronary stents is expected to increase. With improvements in stent materials, such as biocompatible alloys and polymer coatings, and a focus on reducing complications such as restenosis (re-narrowing of the artery), the coronary stent market continues to evolve. Furthermore, innovative technologies like bioresorbable stents, which naturally dissolve after performing their function, are expected to play a significant role in shaping the future of coronary artery treatments. Overall, the coronary stent segment is poised for continued growth, driven by both technological advancements and a growing patient population.

Renal Stents

Renal stents are designed to address kidney-related issues, particularly those caused by a narrowing of the renal arteries, which can lead to conditions such as hypertension and chronic kidney disease. These stents are primarily used in renal artery stenosis (RAS), a condition where the arteries that supply blood to the kidneys become narrowed due to plaque buildup, often resulting in impaired kidney function. Renal stents help restore blood flow to the kidneys, reducing the risk of kidney failure and improving renal function. The increasing prevalence of conditions such as atherosclerosis and hypertension, which contribute to the development of RAS, has spurred demand for renal stents. Additionally, the growing aging population, particularly in developed regions, is likely to continue driving the market for renal stents.

Technological advancements in renal stents have significantly improved their effectiveness. Modern renal stents are designed to be more flexible and durable, allowing for easier placement and reduced risk of complications. Drug-eluting renal stents, which release medication to prevent restenosis, are becoming more popular in clinical practice. As healthcare providers focus on improving patient outcomes and reducing complications associated with renal artery disease, the renal stent segment is expected to grow, particularly as the prevalence of risk factors like diabetes and high blood pressure rises. Furthermore, there is increasing emphasis on non-invasive stent placement procedures, which could further stimulate growth in this subsegment of the implanted stent market.

Carotid Stents

Carotid stents are used to treat carotid artery disease, a condition where the carotid arteries become narrowed or blocked, typically due to the buildup of atherosclerotic plaques. This condition can increase the risk of stroke, making carotid stents a critical intervention. Carotid artery stenting (CAS) is often used as an alternative to carotid endarterectomy, a more invasive surgical procedure. The demand for carotid stents is primarily driven by the rising incidence of stroke and the growing recognition of the benefits of minimally invasive procedures. With improvements in stent design, such as enhanced coating materials and better flexibility, carotid stents are becoming increasingly effective in treating high-risk patients who may not be candidates for traditional surgery.

The carotid stent market is also experiencing growth due to advancements in imaging and placement techniques that allow for greater precision during stent insertion. Additionally, drug-eluting carotid stents, which release medication to prevent restenosis and improve long-term outcomes, are gaining traction. The aging population and increased prevalence of risk factors such as high cholesterol and hypertension are expected to drive further market expansion. Overall, carotid stents play a critical role in preventing strokes and improving quality of life, and their continued development is expected to significantly impact the medical industry in the coming years.

Key Trends and Opportunities in the Implanted Stent Market

One of the key trends in the implanted stent market is the continued advancement of stent technologies. Drug-eluting stents (DES) have revolutionized the treatment of coronary artery disease by reducing the risk of restenosis, and the development of bioresorbable stents presents a promising future for treating various cardiovascular and renal conditions. These bioresorbable stents dissolve after serving their purpose, reducing the need for long-term medical interventions and offering a more patient-friendly option. Additionally, the increasing focus on personalized medicine and patient-specific treatments is encouraging the development of stents that cater to individual needs, improving efficacy and minimizing side effects.

Another significant trend is the rise in minimally invasive procedures. With the growing emphasis on reducing recovery times and improving patient comfort, stent placement via catheterization techniques is becoming more popular. This is particularly evident in coronary and carotid artery interventions. The use of advanced imaging techniques, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), has enabled more precise stent placements, further enhancing patient outcomes. Opportunities in the market lie in addressing the growing demand for stents in emerging markets, where access to healthcare is improving, and the incidence of cardiovascular and renal diseases is on the rise. Manufacturers focusing on affordability and accessibility in these regions are likely to capture a significant share of the market.

Frequently Asked Questions (FAQs)

What is an implanted stent used for?

An implanted stent is used to open up blocked or narrowed arteries, improving blood flow and preventing vessel collapse.

What are the different types of stents?

The main types of stents include coronary stents, renal stents, carotid stents, and other specialty stents, each designed for specific health conditions.

How does a drug-eluting stent work?

A drug-eluting stent releases medication over time to prevent the re-narrowing of the artery after stent placement.

What are the advantages of bioresorbable stents?

Bioresorbable stents dissolve after serving their function, reducing the risk of long-term complications and eliminating the need for a permanent implant.

What is coronary artery disease (CAD)?

Coronary artery disease is a condition where the arteries supplying blood to the heart become narrowed or blocked, often due to plaque buildup.

What are renal stents used for?

Renal stents are used to treat renal artery stenosis, a condition where the arteries leading to the kidneys become narrowed, causing impaired kidney function.

What are carotid stents used for?

Carotid stents are used to treat carotid artery disease, preventing strokes by opening up narrowed or blocked carotid arteries.

Are there risks associated with implanted stents?

Yes, risks include infection, bleeding, restenosis, and, in some cases, blood clots, though these risks

For More Information or Query, Visit @ Implanted Stent Market Size And Forecast 2025-2030